Dear Reader,
Welcome to today's daily dividend and earnings report, where we help you get ready to stay ahead of the game with valuable insights and ratings from top Wall Street analysts.
Please note that while we provide you with valuable information, we are not recommending these companies.
So, let's dive right in...
Below is our latest Dividend Report:
Novo Nordisk A/S
Symbol: NVO
Recent NVO Stock Price: $130.36
Average Analyst Price Target: $140.00 (7.39%)
NVO Market Cap: $585.02B
Expected Ex-Dividend Date for NVO stock: Mar 22 2024
Expected Payment Date for NVO stock: Apr 02 2024
Expected Dividend & Yield for NVO stock: 1.05%
Recent Analyst Action: Michael Nedelcovych, analyst at TD Cowen, reiterates coverage on Novo Nordisk A/S (NVO) stock in the Healthcare sector with a Buy rating and a price target of $155 (1 day ago).
TipRanks.com also reports that Novo Nordisk A/S stock currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $140.00 . The target pricing ranges from a high forecast of $160 down to a low forecast of $120. Novo Nordisk A/S (NVO)’s last closing stock price was $130.36 which would put the average price target at 7.39% upside.Here are 3rd party ratings for NVO stock:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Bottom 26% (186 out of 251)
--------------------------------------------------------------------------
Altria Group, Inc.
Symbol: MO
Recent MO Stock Price: $44.79
Average Analyst Price Target: $43.80 (-2.21%)
MO Market Cap: $78.99B
Expected Ex-Dividend Date for MO stock: Mar 22 2024
Expected Payment Date for MO stock: Apr 30 2024
Expected Dividend & Yield for MO stock: 8.75%
Recent Analyst Action: Lisa Lewandowski, analyst at Bank of America Securities, reiterates coverage on Altria Group, Inc. (MO) stock in the Consumer Defensive sector with a Hold rating and a price target of $45 (1 week ago).
TipRanks.com also reports that Altria Group, Inc. stock currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $43.80 . The target pricing ranges from a high forecast of $47 down to a low forecast of $37. Altria Group, Inc. (MO)’s last closing stock price was $44.79 which would put the average price target at -2.21% upside.Here are 3rd party ratings for MO stock:
- TipRanks.com: Hold
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 25% (62 out of 251)
--------------------------------------------------------------------------
Johnson Controls International plc
Symbol: JCI
Recent JCI Stock Price: $64.13
Average Analyst Price Target: $65.75 (2.53%)
JCI Market Cap: $43.70B
Expected Ex-Dividend Date for JCI stock: Mar 22 2024
Expected Payment Date for JCI stock: Apr 19 2024
Expected Dividend & Yield for JCI stock: 2.31%
Recent Analyst Action: Joe O'Dea, analyst at Wells Fargo, reiterates coverage on Johnson Controls International plc (JCI) stock in the Industrials sector with a Buy rating and a price target of $64 (4 days ago).
TipRanks.com also reports that Johnson Controls International plc stock currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $65.75 . The target pricing ranges from a high forecast of $71 down to a low forecast of $62. Johnson Controls International plc (JCI)’s last closing stock price was $64.13 which would put the average price target at 2.53% upside.Here are 3rd party ratings for JCI stock:
- TipRanks.com: Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 16% (40 out of 251)
--------------------------------------------------------------------------
Equity Residential
Symbol: EQR
Recent EQR Stock Price: $62.68
Average Analyst Price Target: $65.50 (4.50%)
EQR Market Cap: $23.79B
Expected Ex-Dividend Date for EQR stock: Mar 22 2024
Expected Payment Date for EQR stock: Apr 12 2024
Expected Dividend & Yield for EQR stock: 4.31%
Recent Analyst Action: Buck Horne, analyst at Raymond James, reiterates coverage on Equity Residential (EQR) stock in the Real Estate sector with a Hold rating and a price target of n/a (3 days ago).
TipRanks.com also reports that Equity Residential stock currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $65.50 . The target pricing ranges from a high forecast of $70 down to a low forecast of $61. Equity Residential (EQR)’s last closing stock price was $62.68 which would put the average price target at 4.50% upside.Here are 3rd party ratings for EQR stock:
- TipRanks.com: Hold
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Bottom 18% (207 out of 251)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a security on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell before the ex-dividend date, you also are selling away your right to the dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Here's today's Earnings Report...
We has just identified several companies that are expected to release earnings this week (even starting tomorrow). Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Humacyte, Inc.
Symbol: HUMA
Recent Price: $$3.51
Average Analyst Price Target: $7.60 (116.52%)
Market Cap: $$410.58M
Last Year's EPS: -$0.22
Consensus EPS Forecast: -$0.25
Expected Earnings Date: Mar 22 2024
Recent Analyst Action: Allison Bratzel, analyst at Piper Sandler, reiterates coverage on Humacyte, Inc. (HUMA) in the Healthcare sector with a Hold rating and a price target of $4 (1 week ago).
TipRanks.com also reports that Humacyte, Inc. currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $7.60 . The target pricing ranges from a high forecast of $8 down to a low forecast of $15. Humacyte, Inc. (HUMA)’s last closing price was $$3.51 which would put the average price target at 116.52% upside.
Here are 3rd party ratings for HUMA:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Buy, Top 33% (84 out of 251)
Click for chart >>
--------------------------------------------------------------------------
Hyzon Motors Inc.
Symbol: HYZN
Recent Price: $$0.68
Average Analyst Price Target: $1.30 (91.18%)
Market Cap: $$166.60M
Last Year's EPS: -$0.25
Consensus EPS Forecast: -$0.16
Expected Earnings Date: Mar 22 2024
Recent Analyst Action: Craig Irwin, analyst at Roth MKM, reiterates coverage on Hyzon Motors Inc. (HYZN) in the Consumer Cyclical sector with a Buy rating and a price target of $1.6 (2 weeks ago).
TipRanks.com also reports that Hyzon Motors Inc. currently has 2 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $1.30 . The target pricing ranges from a high forecast of $1.6 down to a low forecast of $1. Hyzon Motors Inc. (HYZN)’s last closing price was $$0.68 which would put the average price target at 91.18% upside.
Here are 3rd party ratings for HYZN:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 43% (142 out of 251)
Click for chart >>
--------------------------------------------------------------------------
Barinthus Biotherapeutics plc
Symbol: BRNS
Recent Price: $$2.45
Average Analyst Price Target: $9.31 (280.10%)
Market Cap: $$94.44M
Last Year's EPS: -$0.62
Consensus EPS Forecast: -$0.62
Expected Earnings Date: Mar 22 2024
Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on Barinthus Biotherapeutics plc (BRNS) in the Healthcare sector with a Buy rating and a price target of $15 (2 months ago).
TipRanks.com also reports that Barinthus Biotherapeutics plc currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $9.31 . The target pricing ranges from a high forecast of $7 down to a low forecast of $12. Barinthus Biotherapeutics plc (BRNS)’s last closing price was $$2.45 which would put the average price target at 280.10% upside.
Here are 3rd party ratings for BRNS:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 33% (84 out of 251)
Click for chart >>
--------------------------------------------------------------------------
Allison Transmission Holdings, Inc.
Symbol: ALSN
Recent Price: $$77.65
Average Analyst Price Target: $64.00 (-17.58%)
Market Cap: $$6.77B
Last Year's EPS: $1.76
Consensus EPS Forecast: $1.43
Expected Earnings Date: Mar 22 2024
Recent Analyst Action: Luke Junk, analyst at Robert W. Baird, reiterates coverage on Allison Transmission Holdings, Inc. (ALSN) in the Consumer Cyclical sector with a Hold rating and a price target of $77 (3 weeks ago).
TipRanks.com also reports that Allison Transmission Holdings, Inc. currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $64.00 . The target pricing ranges from a high forecast of $77 down to a low forecast of $55. Allison Transmission Holdings, Inc. (ALSN)’s last closing price was $$77.65 which would put the average price target at -17.58% upside.
Here are 3rd party ratings for ALSN:
- TipRanks.com: Hold
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Strong Buy, Bottom 43% (142 out of 251)
Click for chart >>
--------------------------------------------------------------------------
Just a reminder, securities are very volatile, so please do your own research. Also, while we list the ratings of various 3rd party services, we are not making any recomendations.
To your financial future!
The Editor
DividendPress.com helps you find the best performing dividend stocks. We alert our subscribers of coming ex-dividend dates.